혈액 정화기 시장 : 제품 유형, 기술, 최종 사용자 및 용도별 세계 예측(2025-2030년)

The Blood Purification Devices Market was valued at USD 20.43 billion in 2023, expected to reach USD 21.78 billion in 2024, and is projected to grow at a CAGR of 7.62%, to USD 34.18 billion by 2030.

Blood purification devices are critical in managing various chronic and acute health conditions by removing toxins, waste, and excess fluids from the blood. These devices are pivotal in treating kidney failures, autoimmune diseases, and hospital-acquired infections, among other conditions. The global necessity for blood purification devices stems from the rising prevalence of chronic diseases, an aging population, and increasing awareness of health management techniques. Their applications encompass hemodialysis, hemofiltration, dialysis, and plasmapheresis across diverse end-use settings such as hospitals, clinics, and ambulatory surgical centers.

The market for blood purification devices is significantly influenced by technological advancements, increasing healthcare expenditure, and the growing prevalence of chronic diseases like diabetes and hypertension. Opportunities are emerging in the market, particularly in developing economies where healthcare infrastructures are improving, offering a ripe environment for market penetration and expansion. Recommendations for companies include investing in research and development to innovate more efficient and user-friendly devices, exploring partnerships to enhance distribution networks, and leveraging artificial intelligence for predictive diagnostics that could improve treatment efficacy and device utility.

However, the market also faces several challenges, including high costs associated with blood purification treatments, stringent regulatory frameworks, and potential risks of device-related complications. Furthermore, the dependency on well-established healthcare systems poses a limitation in resource-constrained regions. For businesses, areas of innovation include developing cost-effective portable devices that can serve remote areas and capitalizing on biocompatible materials to enhance device safety and efficiency.

The market is characterized by its dynamic nature driven by rapid technological progressions and evolving healthcare needs. Businesses are advised to keep abreast of technological, regulatory, and demographic trends to effectively navigate this competitive landscape. Overall, success in this market will depend on strategically balancing innovation with accessibility, focusing on personalized medical solutions, and robust collaborations across the healthcare spectrum.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Blood Purification Devices Market

The Blood Purification Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Surging demand for blood purification devices in the treatment of sepsis and septic shock
  • Expanding applications of blood purification devices in removing toxins and managing autoimmune diseases
  • Government initiatives and funding to promote the usage of advanced blood purification technologies
  • Escalating healthcare expenditures driving the adoption of innovative blood purification solutions
• Market Restraints
  • High costs of development, manufacturing, and maintenance of blood purification devices hindering market growth
  • Challenges in ensuring biocompatibility and long-term safety of blood purification devices
• Market Opportunities
  • Growing use of blood purification devices in chronic kidney disease management
  • Rising applications of blood purification devices in liver failure treatments
  • Blood purification devices for sepsis management gaining traction in intensive care units
• Market Challenges
  • Regulatory hurdles delaying the introduction of innovative blood purification devices to the market
  • Challenges in integrating blood purification devices with existing healthcare systems

Porter's Five Forces: A Strategic Tool for Navigating the Blood Purification Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Blood Purification Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Blood Purification Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Blood Purification Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Blood Purification Devices Market

A detailed market share analysis in the Blood Purification Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Blood Purification Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Blood Purification Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Blood Purification Devices Market

A strategic analysis of the Blood Purification Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Purification Devices Market, highlighting leading vendors and their innovative profiles. These include Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International, Biosun Medical, CytoSorbents Corporation, DaVita Inc., ExThera Medical Corporation, Fresenius Medical Care, Gambro, Infomed SA, Jafron Biomedical, Kaneka Corporation, Kawasumi Laboratories, Medtronic, Nipro Corporation, NxStage Medical, Outset Medical, Spectral Medical Inc., Terumo Corporation, and Toray Medical.

Market Segmentation & Coverage

This research report categorizes the Blood Purification Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Accessories, Apheresis Devices, Blood Filters, Dialyzers, Hemoadsorption Columns, and Plasma Separators. The Apheresis Devices is further studied across Centrifugation Devices and Membrane Filtration Devices. The Dialyzers is further studied across High Flux Dialyzers and Low Flux Dialyzers.
• Based on Technique, market is studied across Continuous Renal Replacement Therapy (CRRT), Hemodialysis, and Peritoneal Dialysis. The Continuous Renal Replacement Therapy (CRRT) is further studied across Continuous Venovenous Hemodiafiltration (CVVHDF), Continuous Venovenous Hemodialysis (CVVHD), and Continuous Venovenous Hemofiltration (CVVH). The Hemodialysis is further studied across Conventional Hemodialysis, Nocturnal Hemodialysis, and Short Daily Hemodialysis. The Peritoneal Dialysis is further studied across Automated Peritoneal Dialysis (APD) and Continuous Ambulatory Peritoneal Dialysis (CAPD).
• Based on End User, market is studied across Dialysis Centers, Home Care Settings, and Hospitals.
• Based on Application, market is studied across Acute Kidney Injury Treatment, Chronic Kidney Disease Treatment, End-Stage Renal Disease Treatment, and Sepsis Treatment.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Surging demand for blood purification devices in the treatment of sepsis and septic shock
    • 5.1.1.2. Expanding applications of blood purification devices in removing toxins and managing autoimmune diseases
    • 5.1.1.3. Government initiatives and funding to promote the usage of advanced blood purification technologies
    • 5.1.1.4. Escalating healthcare expenditures driving the adoption of innovative blood purification solutions
  • 5.1.2. Restraints
    • 5.1.2.1. High costs of development, manufacturing, and maintenance of blood purification devices hindering market growth
    • 5.1.2.2. Challenges in ensuring biocompatibility and long-term safety of blood purification devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing use of blood purification devices in chronic kidney disease management
    • 5.1.3.2. Rising applications of blood purification devices in liver failure treatments
    • 5.1.3.3. Blood purification devices for sepsis management gaining traction in intensive care units
  • 5.1.4. Challenges
    • 5.1.4.1. Regulatory hurdles delaying the introduction of innovative blood purification devices to the market
    • 5.1.4.2. Challenges in integrating blood purification devices with existing healthcare systems
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood Purification Devices Market, by Product Type

• 6.1. Introduction
• 6.2. Accessories
• 6.3. Apheresis Devices
  • 6.3.1. Centrifugation Devices
  • 6.3.2. Membrane Filtration Devices
• 6.4. Blood Filters
• 6.5. Dialyzers
  • 6.5.1. High Flux Dialyzers
  • 6.5.2. Low Flux Dialyzers
• 6.6. Hemoadsorption Columns
• 6.7. Plasma Separators

7. Blood Purification Devices Market, by Technique

• 7.1. Introduction
• 7.2. Continuous Renal Replacement Therapy (CRRT)
  • 7.2.1. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 7.2.2. Continuous Venovenous Hemodialysis (CVVHD)
  • 7.2.3. Continuous Venovenous Hemofiltration (CVVH)
• 7.3. Hemodialysis
  • 7.3.1. Conventional Hemodialysis
  • 7.3.2. Nocturnal Hemodialysis
  • 7.3.3. Short Daily Hemodialysis
• 7.4. Peritoneal Dialysis
  • 7.4.1. Automated Peritoneal Dialysis (APD)
  • 7.4.2. Continuous Ambulatory Peritoneal Dialysis (CAPD)

8. Blood Purification Devices Market, by End User

• 8.1. Introduction
• 8.2. Dialysis Centers
• 8.3. Home Care Settings
• 8.4. Hospitals

9. Blood Purification Devices Market, by Application

• 9.1. Introduction
• 9.2. Acute Kidney Injury Treatment
• 9.3. Chronic Kidney Disease Treatment
• 9.4. End-Stage Renal Disease Treatment
• 9.5. Sepsis Treatment

10. Americas Blood Purification Devices Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Blood Purification Devices Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Blood Purification Devices Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Asahi Kasei Corporation
• 2. B. Braun Melsungen AG
• 3. Baxter International
• 4. Biosun Medical
• 5. CytoSorbents Corporation
• 6. DaVita Inc.
• 7. ExThera Medical Corporation
• 8. Fresenius Medical Care
• 9. Gambro
• 10. Infomed SA
• 11. Jafron Biomedical
• 12. Kaneka Corporation
• 13. Kawasumi Laboratories
• 14. Medtronic
• 15. Nipro Corporation
• 16. NxStage Medical
• 17. Outset Medical
• 18. Spectral Medical Inc.
• 19. Terumo Corporation
• 20. Toray Medical